Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Molecular and Cellular Biology, Genetics

Abstract 4330: Astrocytic S1P3 regulates blood-brain/tumor barrier permeability

Anurag N. Paranjape, Brunilde Gril, Stephan Woditschka, Emily Hua, Jeffrey C. Hanson, Xiaolin Wu, Renata Duchnowska, Priscilla K. Brastianos, David L. Liewehr, Seth M. Steinberg, Cody Peer, William D. Figg, Gary T. Pauly, Christina Robinson, Joel P. Schneider and Patricia S. Steeg
Anurag N. Paranjape
National Cancer Institute, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brunilde Gril
National Cancer Institute, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Woditschka
University of North Carolina Wilmington, NC;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily Hua
National Cancer Institute, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey C. Hanson
National Cancer Institute, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaolin Wu
Frederick National Laboratory for Cancer Research, Frederick, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renata Duchnowska
Wojskowy Instytut Medyczny, Warsaw, Poland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Priscilla K. Brastianos
Massachusetts General Hospital, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David L. Liewehr
NCI, Bethesda, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seth M. Steinberg
National Cancer Institute, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cody Peer
National Cancer Institute, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William D. Figg
National Cancer Institute, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary T. Pauly
National Cancer Institute, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Robinson
Frederick National Laboratory for Cancer Research, Frederick, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel P. Schneider
National Cancer Institute, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia S. Steeg
National Cancer Institute, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2017-4330 Published July 2017
  • Article
  • Info & Metrics
Loading
Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC

Abstract

Introduction: Incidence of breast cancer brain metastasis is increasing owing to prolonged life-span and better detection techniques. Prognosis of patients with brain metastases is extremely poor with median survival time of one year. One of the major impediments in treating brain metastases is presence of blood-brain/tumor barrier that limits the permeability of chemotherapeutic drugs into the brain parenchyma. Understanding the mechanisms that regulate blood-brain/tumor barrier permeability in context of brain metastases is imperative to developing successful therapy.

Methods: Mouse models with brain-tropic sublines of MDA-MB-231 (231), JIMT-1, and SUM190 were used to generate breast cancer brain metastases. Using laser capture microscopy, the permeable and non-permeable lesions from mouse brains were isolated and profiled for gene expression using microarray. Immortalized human brain endothelial cells, astrocytes, and pericytes were used for developing in vitro blood-brain/tumor barrier model along with spheres generated with 231-BR6 or JIMT-1-BR3 cells. Secreted cytokines were evaluated using human cytokine profiler. Transendothelial electrical resistance (TEER) was measured using EVOM2 volt/ohm meter.

Results: Gene expression profiling and immunostaining of mouse brains, harboring breast cancer metastases showed that astrocytes at permeable regions express elevated S1P3. Pharmacological inhibition of S1P3 using antagonist TY-52156 (10mg/kg) in mice bearing 231-BR6 brain metastases showed reduction in 3KDa Texas red dextran (TRD) uptake. To investigate the role of S1P3 in regulating barrier permeability, we established in vitro blood-brain/tumor barrier models. Treatment of astrocytes with TY-52156 (2μM) significantly increased mean TEER values (33.9 to 55.8 Ω.cm2; p<0.001, after 24 hrs), while there was a decrease in permeability for TRD (1.9 fold; p<0.0001) and doxorubicin (1.3 folds; p<0.05). Immunostaining on endothelial monolayer showed increased membranous ZO-1 and VE-cadherin expression. The dynamics of increase in TEER was faster when 231-BR6 spheres were included. We observed similar results when S1P3 was knocked down using shRNA. Astrocytes with down-modulated S1P3 showed decreased secretion of various cytokines including IL-6, IL-8, CCL2, CXCL1, and GM-CSF. Inhibition of these cytokines individually using neutralizing antibodies recapitulated the effects of S1P3 inhibition, while treatment of endothelial monolayer with activated cytokines increased the permeability. This study provides a proof of concept for role of S1P3 and downstream cytokine signaling in regulating blood-brain/tumor barrier permeability in breast cancer brain metastases.

Conclusion: Our study shows that astrocytic S1P3 regulates blood-brain/tumor barrier permeability in breast cancer brain metastases by modulating cytokine secretion. This observation might lead to discovery of novel strategies for augmenting drug efficacy.

Citation Format: Anurag N. Paranjape, Brunilde Gril, Stephan Woditschka, Emily Hua, Jeffrey C. Hanson, Xiaolin Wu, Renata Duchnowska, Priscilla K. Brastianos, David L. Liewehr, Seth M. Steinberg, Cody Peer, William D. Figg, Gary T. Pauly, Christina Robinson, Joel P. Schneider, Patricia S. Steeg. Astrocytic S1P3 regulates blood-brain/tumor barrier permeability [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 4330. doi:10.1158/1538-7445.AM2017-4330

  • ©2017 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 77 (13 Supplement)
July 2017
Volume 77, Issue 13 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 4330: Astrocytic S1P3 regulates blood-brain/tumor barrier permeability
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 4330: Astrocytic S1P3 regulates blood-brain/tumor barrier permeability
Anurag N. Paranjape, Brunilde Gril, Stephan Woditschka, Emily Hua, Jeffrey C. Hanson, Xiaolin Wu, Renata Duchnowska, Priscilla K. Brastianos, David L. Liewehr, Seth M. Steinberg, Cody Peer, William D. Figg, Gary T. Pauly, Christina Robinson, Joel P. Schneider and Patricia S. Steeg
Cancer Res July 1 2017 (77) (13 Supplement) 4330; DOI: 10.1158/1538-7445.AM2017-4330

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 4330: Astrocytic S1P3 regulates blood-brain/tumor barrier permeability
Anurag N. Paranjape, Brunilde Gril, Stephan Woditschka, Emily Hua, Jeffrey C. Hanson, Xiaolin Wu, Renata Duchnowska, Priscilla K. Brastianos, David L. Liewehr, Seth M. Steinberg, Cody Peer, William D. Figg, Gary T. Pauly, Christina Robinson, Joel P. Schneider and Patricia S. Steeg
Cancer Res July 1 2017 (77) (13 Supplement) 4330; DOI: 10.1158/1538-7445.AM2017-4330
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Molecular and Cellular Biology, Genetics

  • Abstract LB-266: DAXX promotes de novo lipogenesis in triple-negative breast cancer
  • Abstract LB-322: MicroRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1
  • Abstract LB-319: Development and characterization of ADC999: A novel, potent orally available Wee1 inhibitor with robust antitumor efficacy in vivo
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
  • Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Show more 3

Poster Presentations - Cell Growth Signaling Pathways 7

  • Abstract 4336: Human mesodermal-derived CNS metastasis-associated stromal cells induce a fibrotic response to limit tumor growth
  • Abstract 4334: Interleukin-6 is a key player in stroma-induced resistance to chemotherapy for gastric carcinomas
  • Abstract 4343: Effects of the co-expression of RANTES and IL-6 on the transformed phenotype of breast cancer cells
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement